✦ LIBER ✦

The antitumor immune response in HER-2 positive, metastatic breast cancer patients

✍ Scribed by Zorica D Juranic; Zora Neskovic-Konstantinovic; Tatjana P Stanojkovic; Zeljko Zizak; Tatjana Srdic; Nevenka Stanojevic-Bakic; Dusanka Milosevic; Danica Jovanovic

Book ID: 119905380
Publisher: BioMed Central
Year: 2005
Tongue: English
Weight: 187 KB
Volume: 3
Category: Article
ISSN: 1479-5876
DOI: 10.1186/1479-5876-3-13

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Brain metastases in HER-2 positive metas

Brain metastases in HER-2 positive metastatic breast cancer (MBC) patients

✍ R. Duchnowska; Czartoryska-Arlukowicz; B. Radecka; B. Szostakiewicz; A. Karpinsk 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 269 KB

Adaptive Immune Responses and HER2/neu-P

Adaptive Immune Responses and HER2/neu-Positive Breast Cancer

✍ Eric D. Mortenson, Yang-Xin Fu 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 252 KB

Risk factors for brain relapse in HER2-p

Risk factors for brain relapse in HER2-positive metastatic breast cancer patients

✍ Renata Duchnowska; Rafał Dziadziuszko; Bogumiła Czartoryska-Arłukowicz; Barbara 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 219 KB

Antiangiogenic Therapy in Patients With

Antiangiogenic Therapy in Patients With HER2-Positive Metastatic Breast Cancer: A Case Series

✍ Le Saux, Olivia; You, Benoît; Freyer, Gilles 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 432 KB

Paclitaxel, carboplatin, and trastuzumab

Paclitaxel, carboplatin, and trastuzumab in HER2-positive metastatic breast cancer

✍ Andrew D. Seidman; Larry Norton 📂 Article 📅 2005 🏛 Current Science Inc. 🌐 English ⚖ 136 KB

New therapeutic options significantly im

New therapeutic options significantly improved overall survival in HER-2-positive metastatic breast cancer patients

✍ A. Jaqiello-Gruszfeld; S. Szablowska-Siwik; M. Czerniawska-Meler; A. Skrzypczyk 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB